Conclusion
Conclusion ( 5 Questions)
A nurse is educating a patient who has leukemia and is receiving chemotherapy about the use of filgrastim, a bone marrow stimulant, as part of the treatment. The nurse should tell the patient that filgrastim works by:
This is not a function of filgrastim, but rather of cytoprotective drugs, which are another type of cancer treatment. Cytoprotective drugs work by protecting the kidneys from the harmful effects of chemotherapy drugs, such as cisplatin, which can cause nephrotoxicity (kidney damage). Cytoprotective drugs can prevent or treat nephrotoxicity by increasing urine output, binding to toxic substances, or providing antioxidants⁴.
This is not a function of filgrastim, but rather of erythropoietin, which is another type of colony stimulating factor. Erythropoietin stimulates the production of red blood cells in the bone marrow. Erythropoietin is used to treat anemia, which is a low level of red blood cells that can be caused by chemotherapy or other conditions. Erythropoietin can increase the oxygencarrying capacity of the blood and reduce the need for blood transfusions in patients with anemia⁵.
This is the main function of filgrastim, which is a synthetic (manmade) form of a substance that is naturally produced in your body called a colony stimulating factor. Filgrastim helps the bone marrow to make new white blood cells, especially neutrophils, which are the most common type of white blood cells and play a key role in fighting infections. Filgrastim is used to treat neutropenia, which is a low level of neutrophils that can be caused by chemotherapy or other conditions. Filgrastim can reduce the risk of infection and the need for antibiotics in patients with neutropenia³.
This is not a function of filgrastim, but rather of thrombopoietin, which is another type of colony stimulating factor. Thrombopoietin stimulates the production of platelets in the bone marrow. Platelets are cell fragments that help with blood clotting and prevent bleeding. Thrombopoietin is used to treat thrombocytopenia, which is a low level of platelets that can be caused by chemotherapy or other conditions. Thrombopoietin can reduce the risk of bleeding and bruising in patients with thrombocytopenia.
Choice C reason:
This is the main function of filgrastim, which is a synthetic (manmade) form of a substance that is naturally produced in your body called a colony stimulating factor. Filgrastim helps the bone marrow to make new white blood cells, especially neutrophils, which are the most common type of white blood cells and play a key role in fighting infections. Filgrastim is used to treat neutropenia, which is a low level of neutrophils that can be caused by chemotherapy or other conditions. Filgrastim can reduce the risk of infection and the need for antibiotics in patients with neutropenia³.
Choice A reason:
This is not a function of filgrastim, but rather of cytoprotective drugs, which are another type of cancer treatment. Cytoprotective drugs work by protecting the kidneys from the harmful effects of chemotherapy drugs, such as cisplatin, which can cause nephrotoxicity (kidney damage). Cytoprotective drugs can prevent or treat nephrotoxicity by increasing urine output, binding to toxic substances, or providing antioxidants⁴.
Choice B reason:
This is not a function of filgrastim, but rather of erythropoietin, which is another type of colony stimulating factor. Erythropoietin stimulates the production of red blood cells in the bone marrow. Erythropoietin is used to treat anemia, which is a low level of red blood cells that can be caused by chemotherapy or other conditions. Erythropoietin can increase the oxygencarrying capacity of the blood and reduce the need for blood transfusions in patients with anemia⁵.
Choice D reason:
This is not a function of filgrastim, but rather of thrombopoietin, which is another type of colony stimulating factor. Thrombopoietin stimulates the production of platelets in the bone marrow. Platelets are cell fragments that help with blood clotting and prevent bleeding. Thrombopoietin is used to treat thrombocytopenia, which is a low level of platelets that can be caused by chemotherapy or other conditions. Thrombopoietin can reduce the risk of bleeding and bruising in patients with thrombocytopenia.
